Terminalia catappa Fruit Extract Reverses Streptozotocin-Induced Diabetic Retinopathy in Rats
- PMID: 33121423
- DOI: 10.2174/1871530320666201029142113
Terminalia catappa Fruit Extract Reverses Streptozotocin-Induced Diabetic Retinopathy in Rats
Abstract
Objective and background: Diabetic retinopathy is amongst the most common microvascular complications associated with diabetes. Controlling blood glucose level alone cannot manage diabetes associated complications. Thus, mechanisms that additionally prevent diabetes associated complications are the need of the hour, driving the researchers towards herbal therapies. Terminalia catappa is renowned for its anti-inflammatory, antioxidant, anti-hyperglycemic and anti-angiogenic activity. The current study explores the effect of Terminalia catappa fruit extract on streptozotocin-induced diabetic retinopathy in rats.
Methods: Streptozotocin-induced chronic diabetic rat model was utilized in the study. The hydroalcoholic fruit extract of T. catappa in 20mg/kg, 30mg/kg and 40mg/kg dose and standard anti-diabetic drug, glibenclamide (10mg/kg) was given orally. Retinopathy was evaluated by monitoring lenticular, fundus images and measuring arteriole and venule tortuosity index. Oxidative, angiogenic and inflammatory biomarkers were assessed at the 12th week in the retinal homogenate. Histopathological changes in the retina were also examined. Data was analyzed using one-way Repeated Measure ANOVA followed by the Mann-Whitney test.
Results: The hydro-alcoholic fruit extract of T. catappa significantly decreased blood glucose (p<0.001) in a dose-dependent manner in diabetic rats. Cataract lens was observed in all experimental groups and became clear (grade 0) with 40mg/kg and with 40mg/kg along with glibenclamide at the eighth and sixth week, respectively. The hydro-alcoholic fruit extract in all three doses significantly reduced (p<0.01) arteriole and venule tortuosity in diabetic rats. T. catappa in all three doses in diabetic rats showed a modulatory effect in oxidative, angiogenic and inflammatory biomarkers.
Conclusion: T. catappa reverses diabetes-induced retinopathy by anti-hyperglycemic, anti-oxidant, anti-angiogenic and anti-inflammatory actions, and thus has a potential to be used in diabetes-induced retinopathy.
Keywords: Diabetes; Terminalia catappa; angiogenesis; diabetic retinopathy; inflammation; oxidative stress..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
The modulatory role of prime identified compounds in the bioactive fraction of Homalium zeylanicum in high-fat diet fed-streptozotocin-induced type 2 diabetic rats.J Ethnopharmacol. 2020 Oct 5;260:113099. doi: 10.1016/j.jep.2020.113099. Epub 2020 Jun 11. J Ethnopharmacol. 2020. PMID: 32535241
-
Identification of Phytochemicals and Assessment of Hypoglycemic and Haematological Potentials of Terminalia catappa Linn leaf Extract in Alloxan-induced Diabetic Wistar Rats.Cardiovasc Hematol Agents Med Chem. 2024;22(2):139-150. doi: 10.2174/1871525721666230526152917. Cardiovasc Hematol Agents Med Chem. 2024. PMID: 37246326
-
Antidiabetic activity of Terminalia catappa Linn fruits.J Ethnopharmacol. 2003 Sep;88(1):45-50. doi: 10.1016/s0378-8741(03)00208-3. J Ethnopharmacol. 2003. PMID: 12902049
-
Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications.J Pharm Pharmacol. 2017 Feb;69(2):123-134. doi: 10.1111/jphp.12676. Epub 2016 Dec 20. J Pharm Pharmacol. 2017. PMID: 28000229 Review.
-
Nutrients and Natural Substances for Hypoglycemic Effects and Management in Diabetic Retinopathy.Nutrients. 2025 Mar 30;17(7):1207. doi: 10.3390/nu17071207. Nutrients. 2025. PMID: 40218965 Free PMC article. Review.
Cited by
-
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.PLoS One. 2022 Jul 8;17(7):e0271138. doi: 10.1371/journal.pone.0271138. eCollection 2022. PLoS One. 2022. PMID: 35802659 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical